BioAge Labs (BIOA) Change in Cash (2023 - 2026)

BioAge Labs has disclosed Change in Cash across 4 years of filings, most recently posting $52.9 million for Q1 2026.

• Change in Cash for Q1 2026 came in at $52.9 million, up 154.6% year-over-year; the trailing twelve-month figure through Mar 2026 was -$15.7 million (down 119.59% YoY), and the FY2025 annual result was -$165.5 million, down 150.23% from the prior year.
• Change in Cash came in at $52.9 million for Q1 2026 at BioAge Labs, up from -$26.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $175.4 million in Q3 2024 to a low of -$96.9 million in Q1 2025.
• The 4-year median for Change in Cash is -$7.2 million (2023), against an average of $20.7 million.
• Across the five-year window, Change in Cash soared 307.53% in 2024 and plunged 234.26% in 2025, its largest moves.
• BioAge Labs' Change in Cash stood at -$9.6 million in 2023, then jumped by 307.53% to $19.9 million in 2024, then slumped by 234.26% to -$26.7 million in 2025, then surged by 298.2% to $52.9 million in 2026.
• The last three Change in Cash figures came in at $52.9 million (Q1 2026), -$26.7 million (Q4 2025), and -$4.8 million (Q3 2025), per Business Quant data.